Moreover, human and animal investigations provide evidence that MCP-1 is involved in the development of CVD [62], since heightened MCP-1 has been associated with subclinical atherosclerosis and newly diagnosed CHD [25]. This evidence concerns the gene CCL2 and coronary artery disorder.